
Saturday, April 22, 2023 | 8:30 am to 5:30 pm
Hyatt Regency Lake Tahoe Resort, Incline Village, Nevada
Registration is Closed.
Please contact Karen Sultana for questions at sultanak@med.unr.edu.
Sponsored by: William N. Pennington Cancer Institute
Saturday, April 22, 2023 | 8:30 am to 5:30 pm
Hyatt Regency Lake Tahoe Resort, Incline Village, Nevada
Registration is Closed.
Please contact Karen Sultana for questions at sultanak@med.unr.edu.
Sponsored by: William N. Pennington Cancer Institute
Cancer screening, early detection, and treatment are rapidly changing, with new technologies and therapies being introduced. This year almost 2 million Americans will be diagnosed with cancer. Therefore, it is critical for primary care providers to remain current with guidelines. Understanding the initial cancer therapy is also essential for optimal patient care, as patients often seek information from multiple sources, including their primary providers. This conference will address numerous topics related to common forms of cancer commonly seen and often diagnosed by PCPs.
Following the completion of this activity, participants should be able to:
Physicians, Nurses, Physician Assistants, Medical Researchers, and Pharmacists
This is an in-person CME event
The registration fee is $75 and includes continental breakfast, lunch, networking reception, and CME credit.
The early registration deadline is April 7, 2023. After April 7, 2023, registration increases to $100.
The conference registration deadline is Wednesday, April 14, 2023. Register early, as space is limited.
Discounted registration is available for UNR Med Faculty, Medical Students and Residents. For additional information, please call (775) 784-8078 or sultanak@med.unr.edu.
Cancellations received by April 14, 2023 will receive a full refund less a $25 cancellation fee. Cancellations after April 14, 2023 are non-refundable.
This program is supported by William N. Pennington Cancer Institute.
The contents are those of the author(s) and do not necessarily represent the official views of Renown Health.
Time | Event |
---|---|
8:30 - 9:00 a.m. | Registration, Exhibits, and Continental Breakfast |
9:00 - 9:30 a.m. | Opening Remarks - Reducing the Burden of Cancer 50 Years After the National Cancer Act: Where Were We, Where We Are, Where Are We Going Lee Schwartzberg, M.D., FACP Chief of Medical Oncology and Hematology, Pennington Cancer Institute, Renown Health Professor of Clinical Medicine, University of Nevada, Reno School of Medicine |
9:30 - 10:00 a.m. | The Vision of Pennington Cancer Institute Max Coppes, M.D., Ph.D, MBA Director, Pennington Cancer Institute, Renown Health Professor; Pediatrics and Internal Medicine, University of Nevada, Reno School of Medicine |
10:00 - 10:20 a.m. | Healthy Lifestyle and Cancer Michael Hardacre, M.D. Chief of Radiation Oncology, William N. Pennington Cancer Institute Renown Health |
10:20 - 10:40 a.m. | Hereditary Genetic Testing for Germline Cancers Catherine McCarthy, M.D., FAAFP Family Medicine Specialist, Renown UNR Med Primary Care Professor, Department of Family and Community Medicine, University School of Medicine |
10:40 - 11:00 a.m. | Break and Exhibits |
11:00 - 11:20 a.m. | Screening for Average and High-Risk Individuals Thomas Beidle, M.D. Radiologist, Reno Radiological Associates |
11:20 - 11:40 a.m. | Early Breast Cancer Lee Schwartzberg, M.D., FACP Chief of Medical Oncology and Hematology, Pennington Cancer Institute, Renown Health Professor of Clinical Medicine, University of Nevada, Reno School of Medicine |
11:40 a.m. - 12:10 p.m. |
Breast Cancer Tumor Board | How Disease-Specific Conferences Help Care Thomas Beidle, M.D. Radiologist, Reno Radiological Associates Michelle Chu, M.D., FACS Breast Surgeon, Reno Surgical Associates James B. Harris M.D., FACS Surgical Oncology, Western Surgical Group Professor of Surgery, University of Nevada, Reno Former Chairman of Surgery, University of Nevada Medical Director, Quality and Accreditation, Institute for Cancer, Renown Health Chair, Accreditation for the Commission on Cancer Michael Hardacre, M.D. Chief of Radiation Oncology, Pennington Cancer Institute, Renown Health, Renown Health Jocelyn Mata, LSW, MSW, OSW-C Oncology Social Worker, Pennington Cancer Institute, Renown Health Lee Schwartzberg, M.D., FACP Chief of Medical Oncology and Hematology, Pennington Cancer Institute, Renown Health Professor of Clinical Medicine, University of Nevada, Reno School of Medicine |
12:10 - 1:10 p.m. | Lunch with Presentation by Natera (Non-CME activity) |
1:10 - 1:30 p.m. | Why and How CRC Screening is Changing: Early Onset Epidemic Mike Thomas, M.D., Ph. D Colorectal Surgeon Specialist, Western Surgical Group |
1:30 - 1:50 p.m. | Multimodality Treatment of Early State Rectal Cancer Garrett Green, M.D. Radiation Oncologist, Pennington Cancer Institute, Renown Health, Assistant Clinical Professor of Medicine, University of Nevada, Reno School of Medicine |
1:50 - 2:10 p.m. | Using CT DNA to Make Adjunct Treatment Decisions in Early State Colorectal Cancer Harry Menon, D.O. Hematologist and Medical Oncologist, Pennington Cancer Institute, Renown Health Assistant Professor of Clinical Internal Medicine, University of Nevada, Reno School of Medicine |
2:10 - 2:40 p.m. | Operable HPB Tumor Board | Best Decisions for Tough Cases Christie Elliott, M.D. Forensic Pathologist, Renown Health, Associate Clinical Professor of Pathology, University of Nevada, Reno School of Medicine Garrett Green, M.D. Radiation Oncologist, Pennington Cancer Institute, Renown Health, Assistant Clinical Professor of Medicine, University of Nevada, Reno School of Medicine Christos Galanopoulos, M.D., MBA, MSc, FACS Vice President, Chairman Department of Surgery, Renown Health Jocelyn Mata, LSW, MSW, OSW-C Oncology Social Worker, Pennington Cancer Institute, Renown Health Harry Menon, D.O. Hematologist and Medical Oncologist, Pennington Cancer Institute, Renown Health Assistant Professor of Clinical Internal Medicine, University of Nevada, Reno School of Medicine Nick Manguso, M.D. Surgical Oncologist, Renown Health Randy Zuckerman, M.D. Surgical Oncologist, Renown Health |
2:40 - 3:00 p.m. | Break and Exhibits |
3:00 - 3:20 p.m. | Why Lung Cancer Screening in Northern Nevada Is So Critical Billy Graham, M.D. Pulmonary and Critical Care Attending, Renown Health |
3:20 - 3:40 p.m. | Evolution of Early-Stage Lung Cancer Treatment in the Inoperable Suchit Patel, M.D., Ph. D Radiation Oncologist, Renown Health |
3:40 - 4:00 p.m. | Palliative Care in Oncology-Not Just for End-Of-Life Aaron Dieringer, MD, MPH Assistant Dean of Admissions, Family and Community Medicine |
4:00 - 4:20 p.m. | IO for PCPs: A Different Toxicity Profile Christina Alsop, DNP, AOCNP Oncology Nurse Practitioner, Renown Health |
4:20 - 4:30 p.m. | Closing Remarks Lee Schwartzberg, M.D., FACP Chief of Medical Oncology and Hematology, Pennington Cancer Institute, Renown Health Professor of Clinical Medicine, University of Nevada, Reno School of Medicine |
4:30 - 5:30 p.m. | Networking Reception |
111 County Club Drive
Incline Village, Nevada 89451
Directions
The room rate for conference attendees for Friday, April 21, and Saturday, April 22 is $209 per night (plus $40 resort fee and applicable taxes). Rooms are subject to availability, and the reservation deadline is March 29, 2023.
Guests may make reservations online or by calling (775) 832-1234. Mention the Renown Cancer Institute Conference to receive the discounted group rate.
Hotel Reservation Link for the Cancer Symposium
On-site self-parking is $20 per car, per night for conference attendees for April 21 and April 22.
Exhibit opportunities are available. Please see the exhibit prospectus for additional information.
Please take a moment to complete the Exhibitor Registration Form below. For additional information, please contact Melissa O'Brien mdobrien@med.unr.edu or call 775-784-1983.
As an accredited provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME) the University of Nevada, Reno School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In order to assure that information is presented in a scientific and objective manner, The University of Nevada, Reno School of Medicine requires that anyone in a position to control or influence the content of an accredited activity disclose all financial relationships within the prior 24 months with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. All relevant financial relationships have been mitigated. Following are those disclosures.
The following presenter has disclosed the following relationship with a commercial interest:
Garrett Green, M.D
Grant/Research Support : Novocure
Consultant : Boston Scientific
Speakers' Bureau or Honoraria : Medtronic
Ownership Interest* : Natera, Merck, BMS
Harry Menon, D.O.
Speaker’s Bureau/Honoraria: Merck
Lee Schwartzberg:
Grant/Research Support : Spectrum (institution)
Consultant : AstraZeneca, Daiichi Sankyo, Novartis, Pfizer, Seagen, Coherus, Spectrum, Genentech
Speakers' Bureau or Honoraria : AstraZeneca, Daiichi Sankyo, Merck, Seagen
All other presenters, planners or anyone in a position to control the content of this continuing medical education activity have indicated that neither they nor their spouse/legally recognized domestic partner has any financial relationships with commercial interests related to the content of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nevada, Reno School of Medicine and Renown Health. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education to physicians.
The University of Nevada Reno School of Medicine designates this live activity for a maximum of 6.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The University of Nevada Reno School of Medicine approves this program for 6.00 hours of nursing continuing education credit.
The University of Nevada, Reno School of Medicine is a provider of continuing education credit through the Nevada State Board of Pharmacy. This program is approved for 6.00 hours of continuing education credit for pharmacists.